• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Norway·Healthcare·CARA.OL
Share

Carasent ASA Stocks

NOK 21.1Last Updated 04.12.2024

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

NOK 159.96M

NOK 21.1
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company develops Webdoc, a cloud based EMR-system; and Vårdrummet, a digital platform for interactive health care that enables healthcare providers to communicate with their patients through digital services, such as video, chat, and other channels. It also provides Ad Voca, Ad Opus, and Ad Curis. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA, trad

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.08.2026 03:12

Nvidia's forecast for next year sent its stock soaring after the earnings report. What did the company promise?

27.08.2026 01:36

Nvidia's revenue more than doubled in the second quarter. Why aren't investors impressed?

27.08.2026 00:57

Alibaba has released Qwen, an affordable AI model, for free use

27.08.2026 00:42

An investor from "Betting on a Downturn" hedged against a rise in Nvidia's stock price

26.08.2026 23:49

Samsung Will Pay Swatch Nearly $12 Million Over Digital Copies of Watches in Its App Store

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026